StockData
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. (PMVP) stock

PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.22+0.00 (0.00%)

Close on Nov 18, 2026Market cap $65.22MP/E –Yield –

PMV Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for PMV Pharmaceuticals

PMV Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More PMV Pharmaceuticals figures

See a number that looks wrong?